Form 4 for BC BRUNSWICK CORP
Accepted 2026-02-09 00:00:00 ET · period of report 2026-02-06 · accession 0001623260-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-09 | 2026-02-06 | BC | Dekker Christopher F | EVP. GEN COUNSEL, Sec | S - Sale | $87.38 | -4,981 | 39.7K | -11% | -$435.2K | |
| 2026-02-09 | 2026-02-09 | BC | Dekker Christopher F | EVP. GEN COUNSEL, Sec | G - Gift | $0.00 | -300 | 39.4K | -0.8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-06 | S | D | 4,981 | $87.38 | 39,740 | D | — | — | (F1) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.63 to $88.29 inclusive. (F2) Beneficial holdings include 355 shares acquired pursuant to dividend reinvestment through December 2025. |
| 2 | Common | Common Stock | 2026-02-09 | G | D | 300 | $0.00 | 39,440 | D | — | — |